Melatonin inhibits mast cell activation, indicating its potential as a therapeutic agent in inflammatory diseases

Ann Allergy Asthma Immunol. 2024 May;132(5):659-661. doi: 10.1016/j.anai.2024.01.005. Epub 2024 Jan 20.

Authors

Haozhen Ye¹, Peilin Cheng¹, Bingjie Jin¹, Hongwei Xu¹, Ben Wang²

Affiliations

¹ Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China.
² Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China. Electronic address: [email protected].

PMID: 38253124
DOI: 10.1016/j.anai.2024.01.005

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Cell Degranulation / drug effects
Humans
Inflammation / drug therapy
Inflammation / immunology
Mast Cells* / drug effects
Mast Cells* / immunology
Melatonin* / pharmacology
Melatonin* / therapeutic use

Substances

Melatonin